natgillin/translations-raw huggingface dataset:
THE WORDS “KEEP OUT OF THE SIGHT AND REACH OF CHILDREN” Keep out of the sight and reach of children. 
Čuvati izvan pogleda i dosega djece.
The active substance stimulates active immunity against Aujeszky's disease in pigs. 
Djelatna tvar stimulira aktivni imunitet protiv bolesti Aujeszkoga kod svinja.
Aluminium hydroxide, Mineral oil (Marcol 52), Mannide mono oleate (Arlacel A), Polysorbate 80 (Tween 80), Thiomersal. 
Aluminijev hidroksid, mineralno ulje (Marcol 52), manid monooleat (Arlacel A), polisorbat 80
To avoid foaming, shake gently the vial after reconstitution of the freeze-dried component in the liquid component. 
Da se tekućina ne bi zapjenila, nakon rekonstitucije liofilizirane komponente u tekućoj komponenti bočicu tresite nježno.
Marketing authorisation holder: Zoetis Belgium SA Rue Laid Burniat 1 
Zoetis Belgium SA Rue Laid Burniat 1
In general these reactions disappear within 3 weeks post primary vaccination. 
Općenito, te se reakcije povlače unutar 3 tjedna nakon primarnog cijepljenja.
Name and address of the manufacturers of the biological active substances Zoetis Manufacturing & Research Spain, S.L. 
Naziv i adresa proizvođača biološki djelatnih tvari Zoetis Manufacturing & Research Spain, S.L.
MANUFACTURER'S BATCH NUMBER Lot: {number} for the powder: 
Serija: {broj} za prašak: Serija: {broj} za otapalo:
Solvent for emulsion for injection: 
Otapalo za emulziju za injekciju:
Water for injections 
Manitol Voda za injekcije
Cardboard box with 1 vial of powder and 1 bottle of solvent or 10 vials of powder and 10 bottles of solvent for injection. 
6.5 Osobine i sastav unutarnjeg pakovanja Kartonska kutija s 1 bočicom praška i 1 bočicom otapala ili 10 bočica praška i 10 bočica otapala za injekciju.
INDICATION(S) Active and passive immunisation of pigs against Aujeszky's disease. 
Aktivna i pasivna imunizacija svinja protiv bolesti Aujeszkoga.
SPECIAL WARNING(S) Accidental injection is dangerous - see package insert before use. 
Nehotično je injiciranje opasno - vidi uputu o VMP prije primjene.
Name and address of the manufacturers responsible for batch release Zoetis Manufacturing & Research Spain, S.L. 
Naziv i adresa proizvođača odgovornih za puštanje serije u promet Zoetis Manufacturing & Research Spain, S.L.
Excipient: Thiomersal 
Tiomersal
Live attenuated Aujeszky's disease virus, strain NIA3-783: ≥ 105.2 CCID50* per 2 ml dose of reconstituted emulsion. 
Živi, atenuirani virus bolesti Aujeszkoga, soj NIA3-783: ≥ 105,2 CCID50* po dozi od 2 ml rekonstituirane emulzije.
Shake gently to dissolve the vaccine and transfer the dissolved vaccine into the vial with the solvent. 
Nježno protresite da bi se cjepivo rastopilo i premjestite rastopljeno cjepivo u bočicu s otapalom.
Powder for emulsion for injection: 
Prašak za emulziju za injekciju:
Disodiumhydrogenphosphate Sodiumhydrogenphosphate Mannitol 
Dinatrij-hidrogen-fosfat
WITHDRAWAL PERIOD Zero days. 
Karencija: Nula dana.
Active substance 
Djelatne tvari
ANNEX III LABELLING AND PACKAGE INSERT 
OZNAČAVANJE I UPUTA O VMP
7-ml vials of Type I hydrolytic glass containing 10, 50 or 100 doses of freeze-dried powder. 
I koje sadrže 10, 50 ili 100 doza liofiliziranog praška.
Disposal: read package leaflet. 
Odlaganje: pročitati uputu o VMP
Active immunisation of pigs from the age of 10 weeks to prevent the mortality and clinical signs of Aujeszky's disease and to reduce the excretion of Aujeszky's disease field virus. 
Aktivna imunizacija svinja od 10 tjedana starosti nadalje radi sprječavanja smrtnosti i kliničkih znakova bolesti Aujeszkoga i reduciranja lučenja terenskog virusa bolesti Aujeszkyoga.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER SUBSTANCE(S) 
KVALITATIVNI I KVANTITATIVNI SASTAV DJELATNE(IH) TVARI I DRUGIH SASTOJAKA
20 ml, 100 ml or 200 ml bottles of Type I hydrolytic glass containing solvent for the 10-doses, 50doses or 100-doses presentation or Type II glass rinsed with WFI containing solvent for the 50-doses and 100-doses presentation. 
20 ml, 100 ml ili 200 ml bočice od hidrolitičkog stakla tipa
METHOD AND ROUTE(S) OF ADMINISTRATION For intramuscular use of 1 dose (2 ml) per pig. 
Za intramuskularnu primjenu 1 doze (2 ml) po svinji
Passive immunisation of the progeny of vaccinated gilts and sows to reduce mortality and clinical signs of Aujeszky's disease and to reduce the excretion of Aujeszky's disease field virus. 
Pasivna imunizacija potomstva cijepljenih nazimica i krmača radi reduciranja smrtnosti i kliničkih znakova bolesti Aujeszkoga i reduciranja lučenja terenskog virusa bolesti Aujeszkyoga.
Passive immunisation of piglets from vaccinated gilts and sows to reduce mortality and clinical signs of Aujeszky's disease and to reduce the excretion of Aujeszky's disease field virus. 
Pasivna imunizacija praščića cijepljenih nazimica i krmača radi reduciranja smrtnosti i kliničkih znakova bolesti Aujeszkoga i reduciranja lučenja terenskog virusa bolesti Aujeszkyoga.
Manufacturer responsible for the batch release: Zoetis Manufacturing & Research Spain, S.L. 
Zoetis Manufacturing & Research Spain, S.L.
1 vial with powder for injection (10 doses) and 1 bottle of solvent for injection (20 ml). 
1 bočica s praškom za injekciju (10 doza) i 1 bočica otapala za injekciju (20 ml).
PHARMACEUTICAL FORM Powder and solvent for emulsion for injection 
Prašak i otapalo za emulziju za injekciju
The manufacture, import, possession, sale, supply and/or use of Suvaxyn Aujeszky 783 + O/W may be prohibited in a Member State on the whole or part of its territory pursuant to national legislation. 
Uvoz, proizvodnja, uvoz, posjedovanje, prodaja, opskrba i/ili primjena Suvaxyn Aujeszky 783 + O/W
1 vial with powder for injection (100 doses) and 1 bottle of solvent for injection (200 ml). 
1 bočica s praškom za injekciju (100 doza) i 1 bočica otapala za injekciju (200 ml).
1 vial with powder for injection (50 doses) and 1 bottle of solvent for injection (100 ml). 
1 bočica s praškom za injekciju (50 doza) i 1 bočica otapala za injekciju (100 ml).
Powder: 
Otapalo:
50 doses 
10 doza 50 doza 100 doza
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 
17. BROJ PROIZVODNE SERIJE PROIZVOĐAČA
10 vials with powder for injection (each containing 50 doses) and 10 bottles of solvent for injection (each containing 100 ml). 
10 bočica s praškom za injekciju (svaka sadrži 50 doza) i 10 bočica otapala za injekciju (svaka sadrži
PACKAGE LEAFLET Suvaxyn Aujeszky 783 + O/W, powder and solvent for emulsion for injection for pigs 
Suvaxyn Aujeszky 783 + O/W, prašak i otapalo za emulziju za injekciju za svinje
10 vials with powder for injection (each containing 100 doses) and 10 bottles of solvent for injection (each containing 200 ml). 
10 bočica s praškom za injekciju (svaka sadrži 100 doza) i 10 bočica otapala za injekciju (svaka sadrži
Luxembourg/ Luxemburg Zoetis Belgium SA Tél/Tel. 
Luxembourg/ Luxemburg
10 vials with powder for injection (each containing 10 doses) and 10 bottles of solvent for injection (each containing 20 ml). 
10 bočica s praškom za injekciju (svaka sadrži 10 doza) i 10 bočica otapala za injekciju (svaka sadrži
NAME OF THE VETERINARY MEDICINAL PRODUCT Suvaxyn Aujeszky 783 + O/W, powder and solvent for emulsion for injection for pigs 
UPUTA O VMP ZA: Suvaxyn Aujeszky 783 + O/W, prašak i otapalo za emulziju za injekciju za svinje.
This should be carried out by healthcare professionals. 
To trebaju činiti zdravstveni radnici.
ATC code: A10AB01. 
ATK oznaka: A10AB01.
Date of latest renewal: 18 September 2007 
Datum posljednje obnove odobrenja: 18. rujna 2007.
This may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery). 
To može predstavljati rizik u situacijama u kojima su takve sposobnosti posebno važne (primjerice, vožnja automobila ili rukovanje strojevima).
Trials have indicated a t½ of about 2-5 hours. 
Ispitivanja su pokazala da t½ iznosi približno 2-5 sati.
• Drink alcohol, see Actrapid with alcohol in section 2. 
• pijete alkohol, pogledajte Actrapid s alkoholom u dijelu 2.
Actrapid will start to lower your blood sugar about half an hour after you inject it, and the effect will last for approximately 8 hours. 
Actrapid će početi snižavati razinu šećera u krvi oko pola sata nakon što ga injicirate, a učinak će trajati približno 8 sati.
The data are limited but suggest that the pharmacokinetic profile in children and adolescents may be similar to that in adults. 
Podaci su ograničeni, ali upućuju na to da bi farmakokinetički profil u djece i adolescenata mogao biti sličan onomu u odraslih.
Actrapid which has been frozen must not be used. 
Actrapid koji je bio zamrznut ne smije se primijeniti.
Although stable over time, a certain amount of insulin will initially be adsorbed to the material of the infusion bag. 
Iako je stabilan tijekom vremena, određena količina inzulina inicijalno će se adsorbirati na materijal infuzijske vrećice.
Date of first authorisation: 07 October 2002 
Datum prvog odobrenja: 7. listopada 2002.
You must never inject yourself directly into a vein (intravenously) or muscle (intramuscularly). 
Nikada si ne smijete dati injekciju izravno u venu (intravenski) ili mišić (intramuskularno).
After stabilisation of the patient's blood glucose, adjustment of the dose should be considered (see sections 4.8 and 4.9). 
Nakon što u bolesnika dođe do stabilizacije glikemije treba razmotriti prilagodbu doze (vidjeti dijelove 4.8 i 4.9).
The maximum plasma concentration is reached within 1.5-2.5 hours after subcutaneous administration. 
Maksimalna koncentracija u plazmi postiže se unutar 1,5-2,5 sata nakon supkutane primjene.
Onset of action is within ½ hour, reaches a maximum effect within 1.5-3.5 hours and the entire duration of action is approximately 7-8 hours. 
Počinje djelovati unutar ½ sata, maksimalni učinak postiže se unutar 1,5-3,5 sata, dok ukupno trajanje djelovanja iznosi približno 7-8 sati.
A number of cleavage (hydrolysis) sites on the human insulin molecule have been proposed; none of the metabolites formed following the cleavage are active. 
Predložena su brojna mjesta cijepanja (hidrolize) molekule humanog inzulina; niti jedan od metabolita nastalih nakon cijepanja nije aktivan.
Actrapid dosing is individual and determined in accordance with the needs of the patient. 
Doziranje lijeka Actrapid individualno je i određuje se u skladu s potrebama bolesnika.
Actrapid with alcohol 
Actrapid s alkoholom
The pharmacokinetic profile of Actrapid has been studied in a small number (n=18) of diabetic children (aged 6-12 years) and adolescents (aged 13-17 years). 
Farmakokinetički profil lijeka Actrapid ispitan je u malog broja (n=18) djece (u dobi od 6-12 godina) i adolescenata (u dobi od 13-17 godina) sa šećernom bolešću.
• Screw the needle straight and tightly onto your InnoLet (picture 1A). 
• Navijte iglu ravno i čvrsto na InnoLet (slika 1A).
What Actrapid is and what it is used for 
Što je Actrapid i za što se koristi
What Actrapid looks like and contents of the pack 
Kako Actrapid izgleda i sadržaj pakiranja
However, there were differences between age groups in Cmax, stressing the importance of individual dose titration. 
Ipak, zabilježene su razlike između dobnih skupina s obzirom na Cmax, što naglašava važnost individualne titracije doze.
This should be kept in mind if treatment with the combination of pioglitazone and Actrapid is considered. 
Ovo treba imati na umu ako se razmatra liječenje kombinacijom pioglitazona i lijeka Actrapid.
Withdraw the needle from the skin, then release the pressure on the push-button. 
Izvucite iglu iz kože, a zatim otpustite potisni gumb.
Due to the risk of precipitation in pump catheters, Actrapid should not be used in insulin pumps for continuous subcutaneous insulin infusion. 
Zbog opasnosti od precipitacije u kateterima pumpe, Actrapid se ne smije koristiti u inzulinskim pumpama za kontinuiranu supkutanu infuziju inzulina.
Actrapid is used to reduce the high blood sugar level in patients with diabetes mellitus (diabetes). 
Actrapid se koristi za snižavanje visoke razine šećera u krvi u bolesnika s dijabetesom (šećernom bolešću).
If necessary Actrapid can be given directly into a vein, but this must only be done by healthcare professionals. 
Ako je potrebno, Actrapid se može dati izravno u venu, ali to smije učiniti samo zdravstveni radnik.
What Actrapid is and what it is used for What you need to know before you use Actrapid How to use Actrapid 
Što je Actrapid i za što se koristi Što morate znati prije nego počnete primjenjivati Actrapid
However, the Actrapid dose may need to be adjusted. 
Međutim, možda će biti potrebno prilagoditi dozu lijeka Actrapid.
Subcutaneous injection into the abdominal wall ensures a faster absorption than other injection sites. 
Supkutano injiciranje u trbušnu stijenku osigurava bržu apsorpciju nego druga mjesta injiciranja.
Serious allergic reaction to Actrapid or one of its ingredients (called a systemic allergic reaction) is a very rare side effect, but it can potentially be life threatening. 
Ozbiljna alergijska reakcija na Actrapid ili neki od njegovih sastojaka (takozvana sistemska alergijska reakcija) je vrlo rijetka nuspojava, ali može biti opasna po život.
If any of these apply, do not use Actrapid. 
Ako se nešto od toga odnosi na Vas, nemojte primjenjivati Actrapid.
A clinical trial in a single intensive care unit treating hyperglycaemia (blood glucose above 10 mmol/l) in 204 diabetic and 1344 non-diabetic patients undergoing major surgery showed that normoglycaemia (blood glucose 4.4 - 6.1 mmol/l) induced by intravenous Actrapid reduced mortality by 42% (8% versus 4.6%). 
Kliničko ispitivanje provedeno u jednoj jedinici intenzivnog liječenja u kojoj se liječila hiperglikemija (razina glukoze u krvi iznad 10 mmol/l) u 204 bolesnika sa šećernom bolešću i 1344 bolesnika koji nisu bolovali od šećerne bolesti podvrgnutih velikom kirurškom zahvatu pokazalo je da je normoglikemija (razina glukoze u krvi 4,4-6,1 mmol/l) postignuta intravenskom primjenom lijeka Actrapid smanjila smrtnost za 42% (8% naspram 4,6%).
Actrapid can be used during pregnancy. 
Actrapid se može koristiti u trudnoći.
► If you are treated with Actrapid Penfill and another insulin Penfill cartridge, you should use two insulin delivery systems, one for each type of insulin. 
► Ako se liječite lijekom Actrapid Penfill i još jednim inzulinom u Penfill ulošku, morate koristiti dva pomagala za primjenu inzulina, po jedan za svaku vrstu inzulina.
Actrapid can be used in elderly patients. 
Actrapid se može koristiti u starijih bolesnika.
Talk to your doctor, pharmacist or nurse for advice. 
Obratite se svom liječniku, ljekarniku ili medicinskoj sestri za savjet.
It can be used alone or in combination with intermediate-acting or long-acting insulin before a meal or a snack. 
Može se primjenjivati sam ili u kombinaciji sa srednjedugodjelujućim ili dugodjelujućim inzulinom prije obroka ili međuobroka.
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines. 
Drugi lijekovi i Actrapid Obavijestite svog liječnika, ljekarnika ili medicinsku sestru ako uzimate, nedavno ste uzeli ili biste mogli uzeti bilo koje druge lijekove.
For intravenous use, infusion systems with Actrapid at concentrations from 0.05 international unit/ml to 1.0 international unit/ml human insulin in the infusion fluids 0.9% sodium chloride, 5% dextrose and 10% dextrose with 40 mmol/l potassium chloride using polypropylene infusion bags, are stable at room temperature for 24 hours. 
Za intravensku primjenu, infuzijski sustavi s lijekom Actrapid u koncentraciji od 0,05 internacionalnih jedinica/ml do 1,0 internacionalnih jedinica/ml humanog inzulina u infuzijskoj otopini 0,9% natrijeva klorida, 5% glukoze i 10% glukoze s 40 mmol/l kalijeva klorida, u polipropilenskim infuzijskim vrećicama, stabilni su 24 sata na sobnoj temperaturi.
In case of hypoglycaemia or if hypoglycaemia is suspected, Actrapid must not be injected. 
U slučaju hipoglikemije ili sumnje na hipoglikemiju Actrapid se ne smije injicirati.
Just before use, roll the vial of intermediate- or long-acting (cloudy) insulin between your hands until the liquid is uniformly white and cloudy. 
Neposredno prije primjene provaljajte bočicu srednjedugodjelujućeg ili dugodjelujućeg (zamućenog) inzulina između dlanova sve dok tekućina ne postane jednoliko bijela i zamućena.
► Keep the needle under your skin for at least 6 seconds. 
► Zadržite iglu pod kožom najmanje 6 sekundi.
► If it has not been stored correctly or if it has been frozen, see section 5. 
► ako nije ispravno čuvan ili ako je bio zamrznut, pogledajte dio 5. ► ako inzulin nije bistar i bezbojan.
Treatment with Actrapid helps to prevent complications from your diabetes. 
Liječenje lijekom Actrapid pomaže spriječiti komplikacije šećerne bolesti.
• Hold your InnoLet with the needle upwards and tap the cartridge gently with your finger a few times (picture 1B) to make any air bubbles collect at the top of the cartridge. 
• InnoLet držite iglom okrenutom prema gore te nekoliko puta lagano kucnite prstom po ulošku (slika 1B) kako bi se mjehurići zraka skupili na vrhu uloška.
When two types of insulin are mixed always mix the insulin medicinal products in the same sequence. 
Kada se miješaju dvije različite vrste inzulina, inzulinski pripravci se uvijek moraju miješati istim redoslijedom.
If administration by syringe or intravenous injection is necessary, a vial should be used. 
Ako je potrebna primjena pomoću štrcaljke ili intravenske injekcije potrebno je koristiti bočicu.
If necessary, Actrapid can be administered intravenously. 
Ako je potrebno, Actrapid se može primijeniti intravenski.
Pull off the big outer needle cap and keep it for later. 
Skinite veliki vanjski zatvarač igle i sačuvajte ga za poslije.
Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached. 
Ažurirani RMP treba dostaviti: na zahtjev Europske agencije za lijekove; prilikom svake izmjene sustava za upravljanje rizikom, a naročito kada je ta izmjena rezultat primitka novih informacija koje mogu voditi ka značajnim izmjenama omjera korist/rizik, odnosno kada je izmjena rezultat ostvarenja nekog važnog cilja (u smislu farmakovigilancije ili minimizacije rizika).
If a drop of insulin still does not appear, the pen is defective, and you must use a new one. 
Ako se nakon toga kapljica inzulina ne pojavi, brizgalica je neispravna i morate upotrijebiti novu.
Actrapid is a fast-acting human insulin and may be used in combination with intermediate or longacting insulin medicinal products. 
Actrapid je brzodjelujući humani inzulin i može se koristiti u kombinaciji sa srednjedugodjelujućim ili dugodjelujućim inzulinskim pripravcima.
Use only clear and colourless solutions 
Upotrijebiti samo bistre i bezbojne otopine.
Medicinal products added to the insulin solution may cause degradation of the insulin, e.g. if the medicinal products contain thiols or sulfites. 
Lijekovi koji se dodaju otopini inzulina mogu izazvati razgradnju inzulina, primjerice ako lijek sadrži tiole ili sulfite.
Actrapid is administered subcutaneously by injection in the abdominal wall, the thigh, the gluteal region or the deltoid region. 
Actrapid se primjenjuje supkutanom injekcijom u trbušnu stijenku, bedro, glutealno ili deltoidno područje.
Novo Nordisk Production SAS 45, Avenue d'Orléans F-28000 Chartres France 
Novo Nordisk Production SAS 45, Avenue d'Orléans F-28000 Chartres Francuska
Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment) Water for injections 
Natrijev hidroksid (za podešavanje pH) Kloridna kiselina (za podešavanje pH)
► Keep the needle under your skin for at least 6 seconds to make sure that you have injected all the insulin. 
► Zadržite iglu pod kožom najmanje 6 sekundi da budete sigurni da ste injicirali sav inzulin.
When transferring from other insulin medicinal products, adjustment of the Actrapid dose and the dose of the basal insulin may be necessary. 
Pri prijelazu s drugih inzulinskih pripravaka možda će biti potrebno prilagoditi dozu lijeka Actrapid i dozu bazalnog inzulina.
The solution is clear, colourless and aqueous. 
Otopina je bistra, bezbojna i vodena.
Instructions on how to use Actrapid solution for injection in InnoLet Read the instructions carefully before using your InnoLet. 
Upute za uporabu Actrapid otopine za injekciju u brizgalici InnoLet Prije uporabe brizgalice InnoLet pozorno pročitajte ove upute.
The following substances may reduce the patient's insulin requirement: 
Sljedeće tvari mogu povećati bolesnikovu potrebu za inzulinom:
Hold your FlexPen with the needle pointing upwards and tap the cartridge gently with your finger a few times to make any air bubbles collect at the top of the cartridge. 
FlexPen držite iglom okrenutom prema gore te nekoliko puta lagano kucnite prstom po ulošku kako bi se mjehurići zraka skupili na vrhu uloška.
Combination of Actrapid with pioglitazone 
Kombinacija lijeka Actrapid s pioglitazonom
Actrapid can be used in children and adolescents. 
Actrapid se može koristiti u djece i adolescenata.
Always mix Actrapid and intermediate- or long-acting insulin in the same sequence. 
Uvijek miješajte Actrapid i srednjedugodjelujući ili dugodjelujući inzulin istim redoslijedom.
Patients transferred to Actrapid from another type of insulin may require an increased number of daily injections or a change in dose from that used with their usual insulin medicinal products. 
Bolesnicima koji su prešli na Actrapid s druge vrste inzulina možda će biti potreban veći broj injekcija dnevno ili različita doza nego kod primjene njihovih uobičajenih inzulinskih pripravaka.
You can select doses from 1 to 60 units in increments of 1 unit. 
Odmjeravanjem po 1 jedinicu mogu se birati doze u rasponu od 1 do 60 jedinica.
Actrapid is often given in combination with intermediate-acting or long-acting insulin preparations. 
Actrapid se često daje u kombinaciji sa srednjedugodjelujućim ili dugodjelujućim inzulinskim pripravcima.
Priming to expel air prior to each injection 
Priprema za izbacivanje zraka prije svake injekcije
Inject the air into the vial containing Actrapid. 
Ubrizgajte zrak u bočicu s lijekom Actrapid.
Actrapid contains less than 1 mmol sodium (23 mg) per dose, i.e. Actrapid is essentially ‘sodiumfree'. 
Actrapid sadrži manje od 1 mmol (23 mg) natrija po dozi, tj.
Actrapid contains sodium 
Actrapid sadrži natrij
What you need to know before you use Actrapid Do not use Actrapid 
Što morate znati prije nego počnete primjenjivati Actrapid
Inject the air into the vial containing intermediate- or long-acting insulin and pull out the needle. 
Ubrizgajte zrak u bočicu sa srednjedugodjelujućim ili dugodjelujućim inzulinom i izvucite iglu.
Actrapid is human insulin with a fast-acting effect. 
Actrapid je humani inzulin brzog djelovanja.
Actrapid is indicated for treatment of diabetes mellitus. 
Actrapid je indiciran za liječenje šećerne bolesti.
Actrapid vial (40 international units/ml)/Actrapid vial (100 international units/ml) Vial (type 1 glass) closed with a disc (bromobutyl/polyisoprene rubber) and a protective tamper-proof plastic cap containing 10 ml of solution. 
Actrapid bočica (40 internacionalnih jedinica/ml)/Actrapid bočica (100 internacionalnih jedinica/ml) Bočica (staklo tipa 1) zatvorena pločicom (brombutilna/poliizoprenska guma) i zaštitnim plastičnim zatvaračem s evidencijom otvaranja sadrži 10 ml otopine.
• Always make sure that a drop appears at the needle tip before injection (picture 1B). 
• Prije injiciranja uvijek provjerite je li se na vrhu igle pojavila kapljica (slika 1B).
Draw into the syringe the same amount of air as the dose of Actrapid. 
Navucite u štrcaljku količinu zraka koja je jednaka dozi lijeka Actrapid.
Patients must be instructed to always check the insulin label before each injection to avoid accidental mix-ups between Actrapid and other insulin products. 
Izbjegavanje slučajnih zamjena/medikacijskih pogrešaka Bolesnicima se mora objasniti da prije svakog injiciranja uvijek provjere naljepnicu na inzulinu kako bi izbjegli slučajne zamjene lijeka Actrapid i drugih inzulinskih pripravaka.